8 results
dm2 diagnosis dosing management agonists causes comparison diabeticketoacidosis differential dka drugs eudka euglycemic glp1 hypomagnesemia hypomg inhibitors inpatient mellitus oral
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
Action for Common Diabetes ... sarahthelyon #Diabetes ... #Medications #pharmacology ... #pathophysiology ... #endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Euglycemic Diabetic ... Ketoacidosis (EuDKA ... level < 200 mg/dL Pathophysiology ... #Euglycemic #Diabetic ... diagnosis #management #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... very tolerable medication ... #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP ... insulin in Type 1 Diabetes ... monitors in Type 1 Diabetes ... pocketcardset #Diabetes
Causes of Hypomagnesemia Redistribution: - IV glucose - Correction of diabetic ketoacidosis - IV hyperalimentation - Refeeding
Correction of diabetic ... ketoacidosis ... loss: - Ketoacidosis ... #differential #medications ... #drugs #pharmacology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... very similar to DPP4s ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Diabetic Ketoacidosis (DKA) - Pathogenesis and Clinical Findings • Note: in DKA, body K+ is lost
Diabetic Ketoacidosis ... patient has good renal ... DiabeticKetoacidosis #DKA #pathophysiology ... #endocrinology ... #diabetes
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... empagliflozin and DPP4 ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology
No results found for "Myeloblast basophils pathophysiology endocrinology adrenal diabetes diabetic ketoacidosis medications dpp4 pharmacology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Myeloblast #basophils #pathophysiology #endocrinology #adrenal #diabetes #diabetic #ketoacidosis #medications #dpp4 #pharmacology